LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $135 | -44.0% | 41 | -43.8% | 0.00% | – |
| Q2 2023 | $241 | -0.4% | 73 | 0.0% | 0.00% | – |
| Q1 2023 | $242 | -8.3% | 73 | 0.0% | 0.00% | – |
| Q4 2022 | $264 | -73.6% | 73 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | – | 73 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 73 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 73 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 73 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 73 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $5,627,000 | 1.23% |
| Opaleye Management Inc. | 240,892 | $3,329,000 | 0.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $12,940,000 | 0.32% |
| NEA Management Company, LLC | 526,663 | $7,278,000 | 0.31% |
| Investors Financial Group, LLC | 21,766 | $301,000 | 0.22% |
| Wealth Advisors of Iowa, LLC | 11,760 | $163,000 | 0.11% |
| Blackstone Inc. | 468,145 | $6,470,000 | 0.02% |
| Jefferies Group LLC | 120,651 | $1,667,000 | 0.02% |
| Texas Yale Capital Corp. | 16,000 | $221,000 | 0.02% |
| Prospera Financial Services Inc | 1,088 | $15,000 | 0.01% |